AN-2690 Size:Solid 2 mg ) dose-dependently attenuates formalin-induced paw-licking

) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms

Chemical Name: 3-[(3R)-3-(4-fluorobenzenesulfonamido)-2

Smiles: CN(C)CCN1C(=O)C2C=C(C=C3C=CC=C(C3=2)C1=O)NC(N)=O

3 nM and 3

AN-2690 Size:Solid 2 mg ) dose-dependently attenuates formalin-induced paw-lickingTavaborole, also known as AN 2690 (trade name Kerydin) is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began its Phase 3 trials in December 2010 and was approved in July 2014. Tavaborole inhibits an essential fungal enzyme, Leucyl tRNA synthetase, or LeuRS, required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and cell